WuXi AppTec frees up money for Middle East push
The drugs services giant has stepped up sales of non-core Chinese assets to concentrate on its international expansion, with plans for a base in Saudi Arabia Key Takeaways: The company…
So big but so what? Innovent’s license deal fails to excite investors
The Chinese biotech is selling some cancer drug rights to a Japanese pharma giant for up to $11.4 billion, pocketing a big downpayment, so why did its stock price fall?…
Armed with AstraZeneca deal, Eccogene files for Hong Kong IPO
The Chinese biotech is developing a weight-loss drug in a tablet form that could challenge leading products in the booming anti-obesity market Key Takeaways: The AstraZeneca licensing deal in 2023…
InnoCare licensing deal flops due to lack of upfront cash
The Chinese biotech agreed to sell some of the rights to its flagship drug for a sum that could exceed $2 billion but investors were unhappy with the fine print…
BRIEF: ImmuneOnco to raise $45 million via share placement at 13% discount
Innovative drug developer ImmuneOnco (1541.HK) announced on Thursday that it plans to place 24.2 million new shares, representing about 5.61% of its enlarged share capital, to raise HK$351 million ($45…
Obesity drug maker Sciwind targets IPO, with heavyweight backers
Supported by Tencent and Meituan, the biotech aims to launch a targeted GLP-1 drug next year that could challenge established products, but it faces stiff competition Key Takeaways: • Clinical…
A wild ride for TransThera investors: what’s the story?
The firm’s core drug has passed a minor clinical milestone, but the rally really took off when the stock was included in an array of indices tracked by passive funds…
Recent Articles
WuXi AppTec frees up money for Middle East push
2359.HK
603259.SHG
InnoCare licensing deal flops due to lack of upfront cash
9969.HK
688428.SHG
RELATED ARTICLES
-
Rising profit at WuXi Biologics underscores drug sector rebound
2269.HK -
Fortune smiles again on WuXi AppTec with profit surge
2359.HK 603259.SHG
-
BRIEF: WuXi AppTec raises $975 Million through share placement at 6.9% discount
2359.HK 603259.SHG
-
BRIEF: Meituan’s Keeta enters Dubai, its third Middle East market in 40 days
3690.HK
-
DPC Dash lights up Domino’s global leader board with push into small-town China
1405.HK
-
BRIEF: WuXi XDC to raise $348 million via share placements at 4% discount
2268.HK
-
Work in progress: East Buy reinvents itself – again
1797.HK
